BR100 Decreased By (-0.88%)
BR30 Decreased By (-1.57%)
KSE100 Decreased By (-0.78%)
KSE30 Decreased By (-0.75%)
AGHA 6.70 Increased By ▲ 0.02 (0.3%)
BECO 4.37 No Change ▼ 0.00 (0%)
BML 56.00 Decreased By ▼ -1.32 (-2.3%)
BOP 30.09 Decreased By ▼ -0.26 (-0.86%)
CNERGY 12.95 Decreased By ▼ -0.17 (-1.3%)
CSIL 5.33 Decreased By ▼ -0.08 (-1.48%)
FCCL 51.50 Decreased By ▼ -1.29 (-2.44%)
FFL 14.47 Decreased By ▼ -0.25 (-1.7%)
FNEL 1.22 Increased By ▲ 0.10 (8.93%)
KEL 6.03 Decreased By ▼ -0.06 (-0.99%)
KOSM 5.84 Increased By ▲ 0.11 (1.92%)
LOTCHEM 26.20 Decreased By ▼ -0.26 (-0.98%)
MLCF 91.00 Decreased By ▼ -2.16 (-2.32%)
NBP 164.00 Decreased By ▼ -0.66 (-0.4%)
NCPL 53.00 Decreased By ▼ -2.66 (-4.78%)
NPL 59.40 Decreased By ▼ -1.76 (-2.88%)
OGDC 313.67 Decreased By ▼ -3.06 (-0.97%)
PACE 9.72 Decreased By ▼ -0.15 (-1.52%)
PAEL 35.27 Decreased By ▼ -0.36 (-1.01%)
PIBTL 14.71 Increased By ▲ 0.03 (0.2%)
PPL 221.18 Decreased By ▼ -5.73 (-2.53%)
PRL 90.91 Decreased By ▼ -2.11 (-2.27%)
PTC 58.53 Decreased By ▼ -1.73 (-2.87%)
SSGC 23.30 Decreased By ▼ -0.51 (-2.14%)
TBL 8.78 Increased By ▲ 0.03 (0.34%)
TELE 7.60 Decreased By ▼ -0.20 (-2.56%)
TPL 22.03 Decreased By ▼ -0.32 (-1.43%)
TPLP 12.60 Decreased By ▼ -0.37 (-2.85%)
TREET 21.77 Decreased By ▼ -0.39 (-1.76%)
TRG 55.91 Decreased By ▼ -0.65 (-1.15%)
Markets

CBOT soybeans may test support at $14.01-1/2

  • The contract observes closely a set of projection levels on the uptrend from $13.36-3/4. After breaking below $14.20-1/2, it is falling towards $14.04-1/2.
Published Updated
By

SINGAPORE: The CBOT soybean May contract may test a support at $14.01-1/2 per bushel, a break below could cause a fall to $13.91-1/2.

The contract observes closely a set of projection levels on the uptrend from $13.36-3/4. After breaking below $14.20-1/2, it is falling towards $14.04-1/2.

The current fall looks like more a continuation of the downtrend from the March 8 high of $14.60 than a resumption of the uptrend.

A break above $14.20-1/2 could lead to a gain to $14.31-1/2.

Each reader should consult his or her own professional or other advisers for business, financial or legal advice regarding the products mentioned in the analyses.

Comments

Comments are closed for this article.